Why is Google appealing the antitrust search ruling?
What drove Palantir’s stock surge today?
How will Trump's steel tariff increase impact markets?
Why is Tesla's stock rising despite slumping business?
What caused recent volatility in the stock market?
How are AI layoffs affecting tech companies?
What is behind Meta’s AI team talent loss?
Roche's Multiple Sclerosis Drug Shows Low Disease Activity Over Two Years
benzinga.com/news/health-care/25/05/45700729/roches-multiple-sclerosis-drug-shows-low-disease-activity-over-two-years
Roche Holdings AG (OTC:RHHBY) on Friday announced new 96-week data for fenebrutinib demonstrating that patients with relapsing multiple sclerosis (RMS) maintained no disability progression and low disease activity levels for up to two years.
The latest results for this investigational…
This story appeared on benzinga.com, 2025-05-30 17:17:57.